Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 16.
doi: 10.1002/art.43315. Online ahead of print.

Autoantibody Response Toward Chromatin in Patients With Juvenile Idiopathic Arthritis

Viola Pitkänen  1 , Terhi Remes-Pakarinen  2 , Paula Vähäsalo  3 , Milja Möttönen  4 , Minna-Maija Grönlund  4 , Miika Arvonen  2 , Mikael Knip  5 , Riitta Veijola  3 , Jorma Toppari  4 , Jorma Ilonen  6 , Johanna Lempainen  4 , Anna-Mari Schroderus  1 , Liisa Kröger  2 , Tuure Kinnunen  7
Affiliations

Autoantibody Response Toward Chromatin in Patients With Juvenile Idiopathic Arthritis

Viola Pitkänen et al. Arthritis Rheumatol. .

Abstract

Objective: Patients with juvenile idiopathic arthritis (JIA) frequently exhibit antinuclear antibodies (ANAs), but the specific antigen target recognized by them and the presence of additional autoantibody specificities in patients with JIA remains elusive.

Methods: Plasma samples from 110 untreated patients with active JIA, as well as from 14 children with unspecified arthritis and 151 age- and sex-matched healthy children, were analyzed with multiple modern clinical-grade autoantibody assays, including automated indirect immunofluorescence to screen for ANAs with HEp-2 cells, and specific immune assays to detect reactivity to individual autoantigens. In addition, a HuProt proteome microarray was used to screen for novel autoantibody targets in plasma samples from five patients with ANA-positive JIA and four ANA-negative healthy controls.

Results: Homogeneous nuclear ANA staining, indicating reactivity toward chromatin, was detected in most (61.8%) patients with JIA but rarely in healthy controls (2.6%; P < 0.0001). No antibody reactivity to specific nuclear antigens or other autoantigens associated with connective tissue diseases was detected. However, 20% of patients with JIA harbored antibodies against double-stranded DNA (dsDNA)-nucleosome complexes (compared with 2.6% of controls, P < 0.0001). Finally, the proteome microarray revealed core histone H2A variant H2AFY, part of the nucleosome, to be the most widely recognized human protein by autoantibodies of patients with JIA.

Conclusion: Autoantibody reactivity in JIA primarily targets chromatin, but the epitopes targeted are likely either posttranslationally modified or multimolecule epitopes, such as dsDNA-nucleosome complexes, rather than epitopes on individual native proteins or purified dsDNA.

PubMed Disclaimer

References

REFERENCES

    1. Nigrovic PA, Colbert RA, Holers VM, et al. Biological classification of childhood arthritis: roadmap to a molecular nomenclature. Nat Rev Rheumatol 2021;17(5):257–269.
    1. Storwick JA, Brett AC, Buhler K, et al. Prevalence and titres of antinuclear antibodies in juvenile idiopathic arthritis: a systematic review and meta‐analysis. Autoimmun Rev 2022;21(6):103086.
    1. Saurenmann RK, Levin AV, Feldman BM, et al. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long‐term followup study. Arthritis Rheum 2007;56(2):647–657.
    1. Glerup M, Herlin T, Twilt M. Remission rate is not dependent on the presence of antinuclear antibodies in juvenile idiopathic arthritis. Clin Rheumatol 2017;36(3):671–676.
    1. Nordal EB, Songstad NT, Berntson L, et al. Biomarkers of chronic uveitis in juvenile idiopathic arthritis: predictive value of antihistone antibodies and antinuclear antibodies. J Rheumatol 2009;36(8):1737–1743.

LinkOut - more resources